Request Deal Involvement

Asahi Kasei-backed Veloxis Pharmaceuticals to acquire AiCuris for €780m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Bank of America

financial advisors

Bank of America

Trophic Communications

pr advisors

Trophic Communications

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Freshfields

legal advisors

Freshfields

or

Principals

AICURIS

target

AICURIS

ASAHI KASEI CORPORATION

bidder

ASAHI KASEI CORPORATION

VELOXIS PHARMACEUTICALS

bidder

VELOXIS PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - Asahi Kasei-backed Veloxis Pharmaceuticals to acquire AiCuris for €780m.